NANOVIRICIDES, INC. Revenue from Contract with Customer, Including Assessed Tax
NANOVIRICIDES, INC. (NNVC) reported Revenue from Contract with Customer, Including Assessed Tax of $0 for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-05-15
- NANOVIRICIDES, INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $0.00.
- NANOVIRICIDES, INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $0.00.
- NANOVIRICIDES, INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $0.00.
- NANOVIRICIDES, INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $0.00.
- NANOVIRICIDES, INC. revenue from contract with customer, including assessed tax for fiscal 2025 was $0.00.
- NANOVIRICIDES, INC. revenue from contract with customer, including assessed tax for fiscal 2024 was $0.00.
- NANOVIRICIDES, INC. revenue from contract with customer, including assessed tax for fiscal 2023 was $0.00.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | $0.00 10-Q · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 derived: sum of 4 quarters · filed 2026-02-17 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 derived: sum of 3 quarters · filed 2025-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $0.00 derived: sum of 2 quarters · filed 2025-09-29 | $0.00 derived: sum of 3 quarters · filed 2025-09-29 | $0.00 10-K · filed 2025-09-29 |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-05-15 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | $0.00 10-Q · filed 2025-02-14 | $0.00 derived: sum of 3 quarters · filed 2025-02-14 | $0.00 derived: sum of 4 quarters · filed 2025-02-14 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 derived: sum of 3 quarters · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | $0.00 derived: sum of 2 quarters · filed 2024-09-27 | $0.00 derived: sum of 3 quarters · filed 2024-09-27 | $0.00 10-K · filed 2024-09-27 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $0.00 10-Q · filed 2024-02-14 | $0.00 derived: sum of 3 quarters · filed 2024-02-14 | $0.00 derived: sum of 4 quarters · filed 2024-02-14 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 derived: sum of 3 quarters · filed 2023-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-13 | $0.00 derived: sum of 2 quarters · filed 2023-10-13 | $0.00 derived: sum of 3 quarters · filed 2023-10-13 | $0.00 10-K · filed 2023-10-13 |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2023-05-15 | $0.00 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | $0.00 10-Q · filed 2023-02-14 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | $0.00 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $0.00 10-Q · filed 2022-02-14 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | |||
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $0.00 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | ||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-16 | |||
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-22 | $0.00 derived: sum of 2 quarters · filed 2020-06-22 | $0.00 10-Q · filed 2020-06-22 | |
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $0.00 10-Q · filed 2020-02-14 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-15 | |||
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $0.00 10-Q · filed 2020-02-14 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |